Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study
Nutrients 2020, 12(6), 1553; https://doi.org/10.3390/nu12061553
- Yes, 70k per week is better than 50k. Likewise 100k per week would be even better
Almost 2 months to fully respond to 50,000 IU weekly if no loading dose
by Angelo Fassio 1,*,Giovanni Adami 1OrcID,Maurizio Rossini 1OrcID,Alessandro Giollo 1,Cristian Caimmi 1,Riccardo Bixio 1,Ombretta Viapiana 1,Stefano Milleri 2,Matteo Gatti 1 and Davide Gatti 1
- 1 Rheumatology Unit, University of Verona, 37131 Verona, Italy
- 2 Centro Ricerche Cliniche di Verona SRL, 37131 Verona, Italy
Intervention - non daily category listing has 270 items
along with lists of trials for scores of health problems
50,000 IU every two weeks fights all of the following
Diabetes + Heart Failure + Chronic Pain + Depression + Autism + Breast Cancer + Colon Cancer + Prostate Cancer + Preeclampsia + Premature Birth + Falls + Cognitive Decline + Respiratory Tract Infection + Influenza + Tuberculosis + Chronic Obstructive Pulmonary Disease + Lupus + Inflammatory Bowel Syndrome + Urinary Tract Infection + Poor Sleep + Weight Loss + Growing Pain (22 problems)
an additional 18 health problems are fought if take 50,000 IU weekly
Note: Loading doses raise vitamin D levels >40 ng far faster.
Example: 400,000 IU in a single day, 50,000 IU daily for a week, etc.
The French have over 200 Vitamin D Loading protocols.
Download the PDF from VitaminDWiki
Background: the aim of this study was to investigate the pharmacokinetic (PK) and safety profile of high-dose vitamin D supplementation, comparing different schedules (daily, weekly, or bi-weekly) in an otherwise healthy vitamin D-deficient population.
Methods: single-center, open-label study on healthy subjects deficient in vitamin D (25 (OH)D < 20 ng/mL), randomized to receive cholecalciferol (DIBASE®, Abiogen Pharma, Italy) using three different schedules:
- Group A: 10,000 IU/day for eight weeks followed by 1000 IU/day for four weeks;
- Group B: 50,000 IU/week for 12 weeks,
- Group C: 100,000 IU/every other week for 12 weeks.
Total cumulative doses were: 588,000 IU, 600,000 IU, 600,000 IU. The treatment regimens corresponded to the highest doses allowed for cholecalciferol for the correction of vitamin D deficiency in adults in Italy.
Results: mean 25 (OH)D plasma levels significantly increased from baseline 13.5 ± 3.7 ng/mL to peak values of 81.0 ± 15.0 ng/mL in Group A, 63.6 ± 7.9 ng/mL in Group B and 59.4 ± 12 ng/mL in Group C. On day 28, all subjects showed 25 (OH)D levels ≥ 20 ng/mL and 93.1% had 25 (OH)D levels ≥ 30 ng/mL. On day 56 and 84, all subjects had 25 (OH)D levels ≥ 30 ng/mL. No serious adverse events occurred during the study.
Conclusions: normalization of 25 (OH)D serum levels was quickly attained with all the studied regimens. A more refracted schedule provided a higher systemic 25 (OH)D exposure.
Short URL = https://is.gd/50Kweekly
6565 visitors, last modified 20 Feb, 2023,
Printer Friendly
Follow this page for updates
along with lists of trials for scores of health problems
50,000 IU every two weeks fights all of the following
Diabetes + Heart Failure + Chronic Pain + Depression + Autism + Breast Cancer + Colon Cancer + Prostate Cancer + Preeclampsia + Premature Birth + Falls + Cognitive Decline + Respiratory Tract Infection + Influenza + Tuberculosis + Chronic Obstructive Pulmonary Disease + Lupus + Inflammatory Bowel Syndrome + Urinary Tract Infection + Poor Sleep + Weight Loss + Growing Pain (22 problems)
an additional 18 health problems are fought if take 50,000 IU weekly
Note: Loading doses raise vitamin D levels >40 ng far faster.
Example: 400,000 IU in a single day, 50,000 IU daily for a week, etc.
The French have over 200 Vitamin D Loading protocols.
Download the PDF from VitaminDWiki
Background: the aim of this study was to investigate the pharmacokinetic (PK) and safety profile of high-dose vitamin D supplementation, comparing different schedules (daily, weekly, or bi-weekly) in an otherwise healthy vitamin D-deficient population.
Methods: single-center, open-label study on healthy subjects deficient in vitamin D (25 (OH)D < 20 ng/mL), randomized to receive cholecalciferol (DIBASE®, Abiogen Pharma, Italy) using three different schedules:
- Group A: 10,000 IU/day for eight weeks followed by 1000 IU/day for four weeks;
- Group B: 50,000 IU/week for 12 weeks,
- Group C: 100,000 IU/every other week for 12 weeks.
Total cumulative doses were: 588,000 IU, 600,000 IU, 600,000 IU. The treatment regimens corresponded to the highest doses allowed for cholecalciferol for the correction of vitamin D deficiency in adults in Italy.
Results: mean 25 (OH)D plasma levels significantly increased from baseline 13.5 ± 3.7 ng/mL to peak values of 81.0 ± 15.0 ng/mL in Group A, 63.6 ± 7.9 ng/mL in Group B and 59.4 ± 12 ng/mL in Group C. On day 28, all subjects showed 25 (OH)D levels ≥ 20 ng/mL and 93.1% had 25 (OH)D levels ≥ 30 ng/mL. On day 56 and 84, all subjects had 25 (OH)D levels ≥ 30 ng/mL. No serious adverse events occurred during the study.
Conclusions: normalization of 25 (OH)D serum levels was quickly attained with all the studied regimens. A more refracted schedule provided a higher systemic 25 (OH)D exposure.
Short URL = https://is.gd/50Kweekly
| 6565 visitors, last modified 20 Feb, 2023, |